Forward Pharma A/S ADR | Mutual Funds
Mutual Funds that own Forward Pharma A/S ADR
APO Medical Opportunities
40,220
0.09%
40,220
0.02%
03/31/2018
SPDR S&P International Small Cap ETF
29,406
0.06%
0
0.01%
09/06/2018
Trust for Professional Managers - PMC Diversified Equity Fund
18,725
0.04%
0
0.01%
05/31/2018
APO Medical Opportunities Institutionell
16,000
0.03%
0
0.03%
06/29/2018
3,800
0.01%
3,800
0.07%
06/30/2017
Fidelity Nasdaq Composite Index
3,498
0.01%
0
0%
07/31/2018
Tocqueville Opportunity Fund (The)
1,000
0%
0
0%
03/29/2018
Luxembourg Selection Fund - Amares Strategy Fund
700
0%
0
0.02%
01/31/2018
Rhenman & Partners Fund - Healthcare Equity L/S
0
0%
-36,584
0%
12/31/2017
| Address |
Østergade 24A
Copenhagen CR 1100
Denmark
|
|
Employees
|
- |
| Website |
http://www.forward-pharma.com |
| Updated |
07/08/2019 |
| Forward Pharma is a biopharmaceutical company, which engages in the research and production of medicinal treatment for multiple sclerosis and psoriasis. It focuses on the immunomodulatory compound dimethyl fumarate and its derivatives. The company was founded by Florian Schönharting on July 1, 2005 and is headquartered in Copenhagen, Denmark. |
